{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:28:52Z","timestamp":1761874132412,"version":"build-2065373602"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T00:00:00Z","timestamp":1499212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FE785\/4-1"],"award-info":[{"award-number":["FE785\/4-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.omtn.2017.07.002","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T05:31:54Z","timestamp":1499491914000},"page":"300-316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Anti-adenoviral Artificial MicroRNAs Expressed from AAV9 Vectors Inhibit Human Adenovirus Infection in Immunosuppressed Syrian Hamsters"],"prefix":"10.1016","volume":"8","author":[{"given":"Katrin","family":"Schaar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Pinkert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markian","family":"Pryshliak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline F.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann E.","family":"Tollefson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoling","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Kurreck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William S.","family":"Wold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Klopfleisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karoly","family":"Toth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Fechner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2017.07.002_bib1","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1128\/jcm.34.3.622-627.1996","article-title":"Rapid subgenus identification of human adenovirus isolates by a general PCR","volume":"34","author":"Kidd","year":"1996","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.omtn.2017.07.002_bib2","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/CMR.00052-07","article-title":"Adenoviruses in immunocompromised hosts","volume":"21","author":"Echavarr\u00eda","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.omtn.2017.07.002_bib3","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1086\/320146","article-title":"Lower respiratory tract infections due to adenovirus in hospitalized Korean children: epidemiology, clinical features, and prognosis","volume":"32","author":"Hong","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.omtn.2017.07.002_bib4","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1542\/peds.113.1.e51","article-title":"Adenoviral infections in children: the impact of rapid diagnosis","volume":"113","author":"Rocholl","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.omtn.2017.07.002_bib5","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood-2002-07-2152","article-title":"Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease","volume":"102","author":"Lion","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2017.07.002_bib6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1086\/341770","article-title":"High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation","volume":"35","author":"Schilham","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.omtn.2017.07.002_bib7","first-page":"463569","article-title":"Fatal fulminant hepatic failure from adenovirus in allogeneic bone marrow transplant patients","volume":"2012","author":"Vyas","year":"2012","journal-title":"Case Rep. Infect. Dis."},{"key":"10.1016\/j.omtn.2017.07.002_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2169\/internalmedicine.51.6432","article-title":"Fulminant hepatic failure caused by adenovirus infection mimicking peliosis hepatitis on abdominal computed tomography images after allogeneic hematopoietic stem cell transplantation","volume":"51","author":"Terasako","year":"2012","journal-title":"Intern. Med."},{"key":"10.1016\/j.omtn.2017.07.002_bib9","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/sj.bmt.1702716","article-title":"Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation","volume":"26","author":"Baldwin","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.omtn.2017.07.002_bib10","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1086\/313514","article-title":"Adenovirus infections in hematopoietic stem cell transplant recipients","volume":"29","author":"Howard","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.omtn.2017.07.002_bib11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1128\/CMR.5.3.262","article-title":"Adenoviruses in the immunocompromised host","volume":"5","author":"Hierholzer","year":"1992","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.omtn.2017.07.002_bib12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1128\/CMR.00116-13","article-title":"Adenovirus infections in immunocompetent and immunocompromised patients","volume":"27","author":"Lion","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.omtn.2017.07.002_bib13","doi-asserted-by":"crossref","first-page":"176418","DOI":"10.1155\/2013\/176418","article-title":"Management of adenovirus in children after allogeneic hematopoietic stem cell transplantation","volume":"2013","author":"Wy Ip","year":"2013","journal-title":"Adv. Hematol."},{"key":"10.1016\/j.omtn.2017.07.002_bib14","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3851\/IMP3047","article-title":"Biological antivirals for treatment of adenovirus infections","volume":"21","author":"Schaar","year":"2016","journal-title":"Antivir. Ther. (Lond.)"},{"key":"10.1016\/j.omtn.2017.07.002_bib15","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrd1877","article-title":"Acyclic nucleoside phosphonates: a key class of antiviral drugs","volume":"4","author":"De Clercq","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2017.07.002_bib16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00003495-199958020-00015","article-title":"Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS","volume":"58","author":"Plosker","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.omtn.2017.07.002_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0166-3542(03)00110-4","article-title":"Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney","volume":"59","author":"Ciesla","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.omtn.2017.07.002_bib18","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1073\/pnas.0800200105","article-title":"Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model","volume":"105","author":"Toth","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2017.07.002_bib19","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/tid.12582","article-title":"Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation","volume":"18","author":"Voigt","year":"2016","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.omtn.2017.07.002_bib20","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.bbmt.2011.09.007","article-title":"Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients","volume":"18","author":"Florescu","year":"2012","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.omtn.2017.07.002_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2016.07.021","article-title":"The use of brincidofovir for the treatment of mixed dsDNA viral infection","volume":"83","author":"Camargo","year":"2016","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.omtn.2017.07.002_bib22","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1212\/WNL.0b013e3182904f96","article-title":"Fatal adenovirus encephalomyeloradiculitis in an umbilical cord stem cell transplant recipient","volume":"80","author":"Awosika","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.omtn.2017.07.002_bib23","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/bjd.14369","article-title":"Cutaneous involvement of disseminated adenovirus infection in an allogeneic stem cell transplant recipient","volume":"174","author":"Keyes","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.omtn.2017.07.002_bib24","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2017.07.002_bib25","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.2174\/138161210791792813","article-title":"Development of novel cardiovascular therapeutics from small regulatory RNA molecules--an outline of key requirements","volume":"16","author":"Poller","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.omtn.2017.07.002_bib26","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/anie.200802092","article-title":"RNA interference: from basic research to therapeutic applications","volume":"48","author":"Kurreck","year":"2009","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.omtn.2017.07.002_bib27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.antiviral.2012.03.011","article-title":"Inhibition of adenovirus multiplication by short interfering RNAs directly or indirectly targeting the viral DNA replication machinery","volume":"94","author":"Kneidinger","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.omtn.2017.07.002_bib28","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00705-007-0951-z","article-title":"Silencing E1A mRNA by RNA interference inhibits adenovirus replication","volume":"152","author":"Chung","year":"2007","journal-title":"Arch. Virol."},{"key":"10.1016\/j.omtn.2017.07.002_bib29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.antiviral.2010.08.002","article-title":"Inhibition of adenovirus infections by siRNA-mediated silencing of early and late adenoviral gene functions","volume":"88","author":"Eckstein","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.omtn.2017.07.002_bib30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.antiviral.2015.05.010","article-title":"Enhanced suppression of adenovirus replication by triple combination of anti-adenoviral siRNAs, soluble adenovirus receptor trap sCAR-Fc and cidofovir","volume":"120","author":"Pozzuto","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.omtn.2017.07.002_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.antiviral.2012.10.008","article-title":"An adenoviral vector-based expression and delivery system for the inhibition of wild-type adenovirus replication by artificial microRNAs","volume":"97","author":"Ibri\u0161imovi\u0107","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.omtn.2017.07.002_bib32","doi-asserted-by":"crossref","first-page":"12450","DOI":"10.1128\/JVI.01470-07","article-title":"Ternary complex formation on the adenovirus packaging sequence by the IVa2 and L4 22-kilodalton proteins","volume":"81","author":"Ewing","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2017.07.002_bib33","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1128\/JVI.77.6.3586-3594.2003","article-title":"Requirement of the adenovirus IVa2 protein for virus assembly","volume":"77","author":"Zhang","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2017.07.002_bib34","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1128\/JVI.02097-06","article-title":"Formation of a multiple protein complex on the adenovirus packaging sequence by the IVa2 protein","volume":"81","author":"Tyler","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2017.07.002_bib35","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1099\/0022-1317-81-11-2573","article-title":"Update on adenovirus and its vectors","volume":"81","author":"Russell","year":"2000","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.omtn.2017.07.002_bib36","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1093\/nar\/gkn342","article-title":"Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides","volume":"36","author":"Juliano","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2017.07.002_bib37","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.yjmcc.2004.06.009","article-title":"Phospholamban ablation by RNA interference increases Ca2+ uptake into rat cardiac myocyte sarcoplasmic reticulum","volume":"37","author":"Watanabe","year":"2004","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.omtn.2017.07.002_bib38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.antiviral.2016.08.019","article-title":"Vector-delivered artificial miRNA effectively inhibited replication of Chikungunya virus","volume":"134","author":"Saha","year":"2016","journal-title":"Antiviral Res."},{"key":"10.1016\/j.omtn.2017.07.002_bib39","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/mt.2012.276","article-title":"Application of mutated miR-206 target sites enables skeletal muscle-specific silencing of transgene expression of cardiotropic AAV9 vectors","volume":"21","author":"Geisler","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2017.07.002_bib40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ymthe.2006.03.014","article-title":"Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8","volume":"14","author":"Inagaki","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2017.07.002_bib41","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1073\/pnas.0813207106","article-title":"A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in\u00a0vivo selection","volume":"106","author":"Yang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2017.07.002_bib42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.yrtph.2014.02.007","article-title":"Regulatory acceptance and use of 3R models for pharmaceuticals and chemicals: expert opinions on the state of affairs and the way forward","volume":"69","author":"Schiffelers","year":"2014","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.omtn.2017.07.002_bib43","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/gt.2015.19","article-title":"Expression of an engineered soluble coxsackievirus and adenovirus receptor by a dimeric AAV9 vector inhibits adenovirus infection in mice","volume":"22","author":"R\u00f6ger","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2017.07.002_bib44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.32607\/20758251-2015-7-3-100-107","article-title":"Regulation of human adenovirus replication by rna interference","volume":"7","author":"Nikitenko","year":"2015","journal-title":"Acta Naturae"},{"key":"10.1016\/j.omtn.2017.07.002_bib45","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/sj.gt.3302134","article-title":"Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in\u00a0vivo","volume":"10","author":"McCarty","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2017.07.002_bib46","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/gt.2015.31","article-title":"Adenovirus-mediated artificial MicroRNAs targeting matrix or nucleoprotein genes protect mice against lethal influenza virus challenge","volume":"22","author":"Zhang","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2017.07.002_bib47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/gt.2014.94","article-title":"Sustained inhibition of hepatitis B virus replication in\u00a0vivo using RNAi-activating lentiviruses","volume":"22","author":"Ivacik","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2017.07.002_bib48","doi-asserted-by":"crossref","first-page":"e92188","DOI":"10.1371\/journal.pone.0092188","article-title":"A novel artificial microRNA expressing AAV vector for phospholamban silencing in cardiomyocytes improves Ca2+ uptake into the sarcoplasmic reticulum","volume":"9","author":"Gr\u00f6\u03b2l","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2017.07.002_bib49","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/ana.24618","article-title":"Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model","volume":"79","author":"Stoica","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2017.07.002_bib50","first-page":"434","article-title":"In\u00a0vivo knock-down of multidrug resistance transporters ABCC1 and ABCC2 by AAV-delivered shRNAs and by artificial miRNAs","volume":"7","author":"Borel","year":"2011","journal-title":"J.\u00a0RNAi Gene Silencing"},{"key":"10.1016\/j.omtn.2017.07.002_bib51","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/mt.2008.231","article-title":"Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in\u00a0vitro and in\u00a0vivo","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2017.07.002_bib52","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature04791","article-title":"Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways","volume":"441","author":"Grimm","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2017.07.002_bib53","doi-asserted-by":"crossref","first-page":"e1005392","DOI":"10.1371\/journal.ppat.1005392","article-title":"Correction: Stat2 knockout syrian hamsters support enhanced replication and pathogenicity of human adenovirus, revealing an important role of type I interferon response in viral control","volume":"12","author":"Toth","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtn.2017.07.002_bib54","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1099\/0022-1317-82-8-1917","article-title":"Role of conserved residues in the activity of adenovirus preterminal protein","volume":"82","author":"Botting","year":"2001","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.omtn.2017.07.002_bib55","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature12875","article-title":"Selection and evaluation of clinically relevant AAV variants in a xenograft liver model","volume":"506","author":"Lisowski","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2017.07.002_bib56","doi-asserted-by":"crossref","first-page":"7019","DOI":"10.1128\/JVI.02953-15","article-title":"Identification and validation of small molecules that enhance recombinant adeno-associated virus transduction following high-throughput screens","volume":"90","author":"Nicolson","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2017.07.002_bib57","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/mt.2012.194","article-title":"Endgame: glybera finally recommended for approval as the first gene therapy drug in the European union","volume":"20","author":"Yl\u00e4-Herttuala","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2017.07.002_bib58","doi-asserted-by":"crossref","first-page":"e0146710","DOI":"10.1371\/journal.pone.0146710","article-title":"Inhibition of hepatitis c virus in mice by a small interfering RNA targeting a highly conserved sequence in viral ires pseudoknot","volume":"11","author":"Moon","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2017.07.002_bib59","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1093\/nar\/gkp374","article-title":"p53-dependent antiviral RNA-interference facilitates tumor-selective viral replication","volume":"37","author":"G\u00fcrlevik","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2017.07.002_bib60","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00109-008-0363-x","article-title":"Cardiac-targeted RNA interference mediated by an AAV9 vector improves cardiac function in coxsackievirus B3 cardiomyopathy","volume":"86","author":"Fechner","year":"2008","journal-title":"J.\u00a0Mol. Med. (Berl.)"},{"key":"10.1016\/j.omtn.2017.07.002_bib61","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/gt.2010.141","article-title":"microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors","volume":"18","author":"Geisler","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2017.07.002_bib62","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.vaccine.2010.12.037","article-title":"Vaccine protection against lethal homologous and heterologous challenge using recombinant AAV vectors expressing codon-optimized genes from pandemic swine origin influenza virus (SOIV)","volume":"29","author":"Sipo","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2017.07.002_bib63","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.tvjl.2010.10.018","article-title":"The metastatic cascade is reflected in the transcriptome of metastatic canine mammary carcinomas","volume":"190","author":"Klopfleisch","year":"2011","journal-title":"Vet. J."},{"key":"10.1016\/j.omtn.2017.07.002_bib64","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1021\/pr200112q","article-title":"Is there a malignant progression associated with a linear change in protein expression levels from normal canine mammary gland to metastatic mammary tumors?","volume":"10","author":"Klose","year":"2011","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.omtn.2017.07.002_bib65","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1128\/jvi.55.3.533-546.1985","article-title":"Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products","volume":"55","author":"Harlow","year":"1985","journal-title":"J.\u00a0Virol."}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253117302123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253117302123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:23:50Z","timestamp":1761873830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253117302123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":65,"alternative-id":["S2162253117302123"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2017.07.002","relation":{},"ISSN":["2162-2531"],"issn-type":[{"type":"print","value":"2162-2531"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-adenoviral Artificial MicroRNAs Expressed from AAV9 Vectors Inhibit Human Adenovirus Infection in Immunosuppressed Syrian Hamsters","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2017.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s).","name":"copyright","label":"Copyright"}]}}